Drugs / NGRM-001
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05288725 | Aug 2022 → Jun 2024 | osteoarthritis, knee | Next Generation Regenerative Medicine LLC | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NGRM-001 | “Participants will receive a single intra-articular injection of NGRM-001 on treatment day.” NCT05288725 ↗ |
| Modality | Cell therapy | “that contains Bone Marrow Derived Mesenchymal Stem Cells (BMDMSCs)” NCT05288725 ↗ |
| Route | Other | “single intra-articular injection of NGRM-001” NCT05288725 ↗ |